Advice

following a full submission:

ciclosporin 1mg/mL (0.1%) eye drops emulsion (Verkazia®) is accepted for use within NHSScotland.

Indication under review: treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents.

Ciclosporin eye drops compared with vehicle improved the signs and symptoms associated with VKC, as measured by improvements in keratitis, requirement for rescue medication and development of corneal ulcers.

Medicine details

Medicine name:
ciclosporin (Verkazia)
SMC ID:
SMC2111
Indication:
treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents (until the age of 18)
Pharmaceutical company
Santen
BNF chapter
Eye
Submission type
Full submission
Status
Accepted
Date advice published:
10 December 2018